Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 604 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR How our global activity is tackling cancer prevention in low- and... September 12, 2022 Study Links Mental Health Treatment to Improved Cancer Survival July 10, 2020 Experts Think Medical Detection Dogs Could Be Trained To Sniff Out... March 27, 2020 EMA Recommends Extension of Indications for Tegafur December 24, 2021 Load more HOT NEWS ESMO Congress 2022, 9-13 September How you can do your part in the AI transformation of... Themes in Improving Supportive Care for People With Cancer: 2022 MASCC... Cancer Drug Lynparza Found to Lower Risk of Death and Recurrence...
